Tag: Hemato Oncology Testing Market

Hemato Oncology Testing Market
Medical Devices

Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer

Major Growth Drivers: Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for developing new assays. On the other hand, Uncertain reimbursement scenario in different regions is expected to restrain the growth of this market during the forecast period. Expected Revenue Growth: [116 Pages Report] The hemato oncology testing market is projected to reach … Continue reading Hemato – Oncology Testing Market Worth USD 4.0 Billion : Increasing Incidence Of Hematologic Cancer

Unknown's avatarsasha sharma
Medical Devices

Global Hemato Oncology Testing Market is Going Through Major Technological Transformations

Abbott Laboratories (US) was the second-largest player in the market in 2018. Over the last few years, the company has been investing approximately 6-9% of its total revenue on R&D. As a result, the company has been able to introduce products, such as Abbott RealTime IDH1 and Abbott RealTime IDH2 assay kits, into the market. What the Market Looks Like? The hemato oncology testing market is projected … Continue reading Global Hemato Oncology Testing Market is Going Through Major Technological Transformations

Unknown's avatarsasha sharma